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February 7, 2006:683–91dentification of important new genome-environment interactions
n DCM pathogenesis (3) and also have implications for the
linical management of DCM patients.
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EPLY
e appreciate the interest in our recent review (1) of the genetic
asis of dilated cardiomyopathy from Drs. Poller, Schultheiss, and
ühl. We agree with the first point that the screening of healthy,
nselected populations is always important to more fully under-
tand genetic variation. We also agree with the general premise of
he second point that understanding gene/environment interac-
ions can be helpful, and at times essential, for understanding the
athogenesis and progression of genetic disease.
We also suggest that the first point of Drs Poller and colleagues
“ . . . unless representative healthy populations are screened . . . ”)
ay be even more important for their work (2) to ascertain any role
f viruses in causing idiopathic dilated cardiomyopathy (IDC). In
heir study only myocardial samples from patients with IDC were
xamined for virus, but no myocardial samples from any control
roup (e.g., ischemic cardiomyopathy, or a “representative healthy
opulation”) were reported. This raises the question of whether
iruses, ubiquitous in all living organisms and perhaps equally so in
ontrol myocardium, are relevant for IDC.
Although it is likely that environmental influences affect pen-
trance and phenotype, it is also clear that a great deal of
henotypic variation can be attributed to epigenetic variation
ndependent of environmental influence. Transcriptionally compe-
ent retrotransposons likely number in the thousands in mamma-
ian genomes, and, for example, have been shown to cause the
onsiderable phenotypic variation that is routinely observed in
sogenic mice strains (3). Understanding the genetic, epigenetic,
nd environmental factors that cause or modify human disease will
equire a great deal of careful effort supported by the most robust
ontrols possible. iRay E. Hershberger, MD
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ardiovascular Manifestations
f Carbon Monoxide Poisoning
e read with interest the report by Satran et al. (1) on the
ardiovascular manifestations of carbon monoxide (CO) poison-
ng. In the Hospital Rı´o Hortega of Valladolid (Spain), we
ollowed CO poisonings prospectively for two years (2). The
rotocol included, among other parameters, carboxyhemoglobin
COHb) levels, electrocardiogram (ECG), creatine kinase (CK)
nd CK-MB. During the study period studied, 154 patients were
ncluded, of whom 20% (n 31) presented sinusal tachycardia, 5%
n  8) arrhythmias (mainly auricular fibrillation), and 4% (n  6)
schemic changes, including one patient in whom cardiac cathe-
erization was carried out without findings of coronary artery
isease. Eight (7.2%) adult patients and 25.6% (n 10) of patients
nder 10 years of age had elevated CK levels. Similarly, CK-MB
evels were elevated in 1.8% (n  2) of adults and in 12.7% (n 
) of children (p  0.01) (2). In our series, the percentage of
atients with cardiovascular manifestations is inferior to that
escribed by Satran et al. (1). We suggest that this is because our
tudy population included all CO poisonings, of which 40% were
ild (COHb 25%), whereas Satran et al. (1) included only
oderate or severe poisonings. The fact that elevated CK and
K-MB levels occur more frequently in children than in adults
uggests a greater toxicity or affinity of CO for the pediatric
usculature, although this hypothesis remains to be verified.
Satran et al. (1) report that, in an unspecified number of
atients, the etiology of the CO poisoning was fire exposure, and
hat eight patients died owing to burn injuries (1), but they make
o reference to plasma lactate concentrations. Lactate is the
rincipal marker of cyanide (CN) in the blood of patients who
nhale fire smoke, and levels greater than 10 mmol/l suggest that,
n these patients, CN plays a more important role than does CO
3,4). We suggest that a percentage of the myocardial ischemias
escribed by Satran et al. (1) may be due to fire smoke inhalation
yndrome and not solely to CO poisoning. Smoke from fires
ontains a mixture of gases, but of these it is CO and CN that
rovoke tissue hypoxia and may lead to death (5). Although the
rotagonism of CO in the multifactorial hypoxia of fire smoke
nhalation syndrome is well known, the role of CN is less so (4).
